TipRanks
Go Ultimate75% OFF

Garen Bohlin Insider Profile

4 Followers

Garen Bohlin, Director at Karyopharm Therapeutics, holds 18.52K shares in Karyopharm Therapeutics (Ticker: KPTI), holds 0.00 shares in Tetraphase (Ticker: TTPH), holds 71.00K shares in Collegium Pharmaceutical (Ticker: COLL).

Garen Bohlin's Trading History

KPTI
Karyopharm Therapeutics
May 26, 2026DirectorUninformative Buy―$999.92
COLL
Collegium Pharmaceutical
May 18, 2026DirectorUninformative Buy―$1.72M
TARA
Protara Therapeutics
Nov 14, 2017DirectorUninformative Buy102.90K$122.62K
TTPH
Tetraphase
―――$0.00

You May Also Like

Garen Bohlin insider profile FAQ

What is the percentage of profitable transactions made by Garen Bohlin?
The percentage of profitable transactions made by Garen Bohlin is 50%.
What is the average return per transaction made by Garen Bohlin?
The average return per transaction made by Garen Bohlin is -7.80%.
What stocks does Garen Bohlin hold?
Garen Bohlin holds: KPTI, TTPH, COLL, TARA stocks.
What was Garen Bohlin's most profitable transaction?
Garen Bohlin’s most profitable transaction was an Informative Sell of COLL stock on May 13, 2026. The return on the trade was 30.50%.
What is Garen Bohlin's role in Karyopharm Therapeutics?
Garen Bohlin's role in Karyopharm Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.